Vav proteins belong to the family of guanine-nucleotide-exchange factors for the Rho/Rac family of small G-proteins. In addition, they serve as important adapter proteins for the activation of PLCγ (phospholipase Cγ) isoforms by ITAM (immunoreceptor tyrosine-based activation motif) receptors, including the platelet collagen receptor GPVI (glycoprotein VI). Vav proteins are also regulated downstream of integrins, including the major platelet integrin αIIbβ3, which has recently been shown to regulate PLCγ2. In the present study, we have investigated the role of Vav family proteins in filopodia and lamellipodia formation on fibrinogen using platelets deficient in Vav1 and Vav3. Wild-type mouse platelets undergo a limited degree of spreading on fibrinogen, characterized by the formation of numerous filopodia and limited lamellipodia structures. Platelets deficient in Vav1 and Vav3 exhibit reduced filopodia and lamellipodia formation during spreading on fibrinogen. This is accompanied by reduced αIIbβ3-mediated PLCγ2 tyrosine phosphorylation and reduced Ca2+ mobilization. In contrast, the G-protein agonist thrombin stimulates full spreading of control and Vav1/3-deficient platelets. Consistent with this, stimulation of F-actin (filamentous actin) formation and Rac activation by thrombin is not altered in Vav-deficient cells. These results demonstrate that Vav1 and Vav3 are required for optimal spreading and regulation of PLCγ2 by integrin αIIbβ3, but that their requirement is by-passed upon G-protein receptor activation.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
February 2007
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
January 12 2007
Vav family proteins are required for optimal regulation of PLCγ2 by integrin αIIbβ3 Available to Purchase
Andrew C. Pearce;
Andrew C. Pearce
1
*Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
1To whom correspondence should be addressed (email [email protected]).
Search for other works by this author on:
Owen J. T. Mccarty;
Owen J. T. Mccarty
2
*Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
Search for other works by this author on:
Simon D. J. Calaminus;
Simon D. J. Calaminus
*Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
Search for other works by this author on:
Elena Vigorito;
Elena Vigorito
†Laboratory for Lymphocyte Signalling and Development, Molecular Immunology Programme, The Babraham Institute, Babraham, Cambridge CB2 4AT, U.K.
Search for other works by this author on:
Martin Turner;
Martin Turner
†Laboratory for Lymphocyte Signalling and Development, Molecular Immunology Programme, The Babraham Institute, Babraham, Cambridge CB2 4AT, U.K.
Search for other works by this author on:
Steve P. Watson
Steve P. Watson
*Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 04 2006
Accepted:
October 23 2006
Accepted Manuscript online:
October 23 2006
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London
2007
Biochem J (2007) 401 (3): 753–761.
Article history
Received:
October 04 2006
Accepted:
October 23 2006
Accepted Manuscript online:
October 23 2006
Citation
Andrew C. Pearce, Owen J. T. Mccarty, Simon D. J. Calaminus, Elena Vigorito, Martin Turner, Steve P. Watson; Vav family proteins are required for optimal regulation of PLCγ2 by integrin αIIbβ3. Biochem J 1 February 2007; 401 (3): 753–761. doi: https://doi.org/10.1042/BJ20061508
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |